145 related articles for article (PubMed ID: 7041568)
1. Effect of synthetic PAF-acether on human neutrophil function.
Czarnetzki BM; Benveniste J
Agents Actions; 1981 Dec; 11(6-7):549-50. PubMed ID: 7041568
[TBL] [Abstract][Full Text] [Related]
2. Failure of PAF-acether to induce in vivo neutrophil migration.
Cunha FQ; Heluy-Neto NE; Klein A; Souza GE; Ferreira SH
Agents Actions; 1988 Aug; 25(1-2):191-4. PubMed ID: 3055873
[TBL] [Abstract][Full Text] [Related]
3. Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.
Czarneztki BM
Chem Phys Lipids; 1982 Oct; 31(2):205-11. PubMed ID: 6814773
[TBL] [Abstract][Full Text] [Related]
4. Effect of 1-O-octadecyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF-acether) on leukocytes I. Analysis of the in vitro migration of human neutrophils.
Czarnetzki BM; Benveniste J
Chem Phys Lipids; 1981 Dec; 29(4):317-26. PubMed ID: 7318049
[TBL] [Abstract][Full Text] [Related]
5. Platelet-activating factor (PAF-acether), an activator of neutrophil functions.
Jouvin-Marche E; Poitevin B; Benveniste J
Agents Actions; 1982 Dec; 12(5-6):716-20. PubMed ID: 6299078
[TBL] [Abstract][Full Text] [Related]
6. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
Wardlaw AJ; Moqbel R; Cromwell O; Kay AB
J Clin Invest; 1986 Dec; 78(6):1701-6. PubMed ID: 3023451
[TBL] [Abstract][Full Text] [Related]
7. Acetyl glyceryl ether phosphorylcholine (PAF-acether) and leukotriene B4-mediated neutrophil chemotaxis through an intact endothelial cell monolayer.
Hopkins NK; Schaub RG; Gorman RR
Biochim Biophys Acta; 1984 Sep; 805(1):30-6. PubMed ID: 6089913
[TBL] [Abstract][Full Text] [Related]
8. Effects of proinflammatory mediators on canine neutrophil chemotaxis and aggregation.
Strøm H; Thomsen MK
Vet Immunol Immunopathol; 1990 Jul; 25(3):209-17. PubMed ID: 2396362
[TBL] [Abstract][Full Text] [Related]
9. Chemotactic effect of PAF-acether on peritoneal eosinophils from normal rats.
Martins MA; Etienne A; Soulard C; Domingo MT; Braquet P
Braz J Med Biol Res; 1989; 22(9):1151-4. PubMed ID: 2636011
[TBL] [Abstract][Full Text] [Related]
10. Differential sensitivities of purified human eosinophils and neutrophils to defined chemotaxins.
Morita E; Schröder JM; Christophers E
Scand J Immunol; 1989 Jun; 29(6):709-16. PubMed ID: 2544988
[TBL] [Abstract][Full Text] [Related]
11. Paf-acether generates chemiluminescence in human neutrophils in the absence of cytochalasin B.
Poitevin B; Roubin R; Benveniste J
Immunopharmacology; 1984 Apr; 7(2):135-44. PubMed ID: 6724877
[TBL] [Abstract][Full Text] [Related]
12. Cooperation between platelets and neutrophils for paf-acether (platelet-activating factor) formation.
Coëffier E; Delautier D; Le Couedic JP; Chignard M; Denizot Y; Benveniste J
J Leukoc Biol; 1990 Mar; 47(3):234-43. PubMed ID: 2307906
[TBL] [Abstract][Full Text] [Related]
13. Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4.
Hopkins NK; Lin AH; Gorman RR
Biochim Biophys Acta; 1983 Oct; 763(3):276-83. PubMed ID: 6313071
[TBL] [Abstract][Full Text] [Related]
14. Biologic properties of LTB4 and paf-acether in vivo in human skin.
Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Ca2+ antagonist nifedipine on the release of platelet-activating factor (PAF-acether), slow-reacting substance and beta-glucuronidase from human neutrophils.
Jouvin-Marche E; Cerrina J; Coëffier E; Duroux P; Benveniste J
Eur J Pharmacol; 1983 Apr; 89(1-2):19-26. PubMed ID: 6134631
[TBL] [Abstract][Full Text] [Related]
16. Relaxation of the guinea-pig trachea induced by platelet-activating factor and by serotonin.
Prancan A; Lefort J; Barton M; Vargaftig BB
Eur J Pharmacol; 1982 May; 80(1):29-35. PubMed ID: 7095003
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
[TBL] [Abstract][Full Text] [Related]
18. Specific desensitization of rabbit platelets by platelet-activating factor (PAF-acether) and derivatives.
Keraly CL; Benveniste J
Br J Haematol; 1982 Jun; 51(2):313-22. PubMed ID: 7082588
[TBL] [Abstract][Full Text] [Related]
19. Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
Sánchez-Crespo M; Alonso F; Iñarrea P; Alvarez V; Egido J
Immunopharmacology; 1982 Apr; 4(2):173-85. PubMed ID: 7085259
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF-acether): present status.
Benveniste J
Agents Actions; 1981 Dec; 11(6-7):542-4. PubMed ID: 6176101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
